Albemarle Idles Kemerton Train As Investors Weigh Margins And Valuation
Albemarle (NYSE:ALB) has idled its remaining operating train at the Kemerton lithium hydroxide plant in Western Australia to cut costs and focus on higher margin production. The move follows prolonged lithium price fluctuations and a reassessment of where its lowest cost, most flexible capacity sits across the portfolio. The company expects the decision to be accretive to earnings from Q2 2026 and does not expect a change to projected 2026 volumes. For investors watching NYSE:ALB, this...
Albemarle (NYSE:ALB) has idled its remaining operating train at the Kemerton lithium hydroxide plant in Western Australia to cut costs and focus on higher margin production. The move follows prolonged lithium price fluctuations and a reassessment of where its lowest cost, most flexible capacity sits across the portfolio. The company expects the decision to be accretive to earnings from Q2 2026 and does not expect a change to projected 2026 volumes. For investors watching NYSE:ALB, this...